Skip to main content

Clearside Biomedical, Inc.

CLSDDelisted Dec 8, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001539029

Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Clearside Biomedical, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of CLSD: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders6760−7
Shares21.0M16.4M−4.64M (−22.1%)
Value$57.8M$37.5M−$20.3M (−35.1%)

New holders (9)

Institutions that held Clearside Biomedical, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CLSD in Q1 2022
InstitutionSharesValue% of portfolio
Marshall Wace, LLP412,031$943.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.79,252$181.0K0.00%
Gsa Capital Partners LLP78,274$179.0K0.02%
Bailard, Inc.25,600$59.0K0.00%
Two Sigma Securities, LLC21,652$50.0K0.01%
Algert Global LLC15,410$35.0K0.00%
Bayesian Capital Management, LP15,500$35.0K0.01%
Mackenzie Financial Corp11,757$27.0K0.00%
C M Bidwell & Associates Ltd1,165$3.00K0.00%

Sold out (16)

Institutions that held Clearside Biomedical, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of CLSD in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
RTW Investments, LP3,806,018$10.5M
Walleye Capital LLC103,771$285.0K
Jump Financial, LLC67,976$187.0K
Ameriprise Financial Inc38,542$106.0K
Wedbush Securities Inc36,239$100.0K
Caxton Associates LP35,916$99.0K
ExodusPoint Capital Management, LP29,385$81.0K
Balyasny Asset Management LLC18,763$52.0K
Old Mission Capital LLC16,362$45.0K
Virtu Financial LLC14,573$40.0K
Exencial Wealth Advisors, LLC14,064$39.0K
Alpine Global Management, LLC13,743$38.0K
Walleye Trading LLC11,456$32.0K
PDT Partners, LLC10,616$29.0K
Barclays PLC500$1.00K
FMR LLC127$0